EBioMedicine,
Год журнала:
2021,
Номер
68, С. 103435 - 103435
Опубликована: Июнь 1, 2021
The
human
gut
microbiota,
comprised
of
a
diverse
microbial
ecosystem,
consists
hundreds
groups
species
that
are
relatively
stable
in
healthy
individuals,
but
its
composition
can
change
rapidly
as
result
illness,
age,
diet,
antibiotic
use,
host
genetics,
and
inflammation.
Recent
reports
have
shown
the
microbiome
may
be
implicated
tuberculosis
(TB)
infection
[[1]Mori
G.
Morrison
M.
Blumenthal
A.
Microbiome-immune
interactions
tuberculosis.PLOS
Pathog.
2021;
17e1009377https://doi.org/10.1371/journal.ppat.1009377Crossref
PubMed
Scopus
(4)
Google
Scholar,[2]Namasivayam
S.
Maiga
Yuan
W.
Thovarai
V.
Costa
D.L.
Mittereder
L.R.
et
al.Longitudinal
profiling
reveals
persistent
intestinal
dysbiosis
triggered
by
conventional
anti-tuberculosis
therapy.Microbiome.
2017;
5:
71https://doi.org/10.1186/s40168-017-0286-2Crossref
(58)
Scholar].
TB
is
one
most
fatal
infectious
disease
caused
Mycobacterium
complex
remains
major
cause
global
morbidity
mortality
[[3]Kone
B.
Somboro
A.M.
Holl
J.L.
Baya
Togo
A.A.
Sarro
Y.D.S.
al.Exploring
usefulness
molecular
epidemiology
Africa:
systematic
review.Int
J
Mol
Epidemiol
Genet.
2020;
11:
1-15PubMed
associated
metabolites
likely
to
play
role
susceptibility
progression
severity
disease.
Changes
structure
populations
could
impact
immunity
signaling.
Gaining
an
in-depth
understanding
parameters
relationship
reveal
key-elements
predict
modulate
progression,
severity,
treatment
outcomes
and,
possibly
re-infection.
inflammation
mostly
described
capacity
certain
produce
specific
enzymes
ferment
nutrients
into
absorbable
forms,
such
carbohydrates
form
short-chain
fatty
acids
(SCFAs)
possess
anti-inflammatory
immunomodulatory
properties
[[4]Eribo
O.A.
du
Plessis
N.
Ozturk
Guler
R.
Walzl
Chegou
N.N.
response:
guilty
or
not
guilty?.Cell
Life
Sci.
77:
1497-1509Crossref
(12)
Moreover,
other
components
microbes
like
cell
capsule
carbohydrates,
lipopolysaccharides,
endotoxins,
produced
maintain
integrity
wall,
intervene
production
vitamins,
regulation
endocrine
hormones,
energy
activation,
stimulation
inhibition
key
immune
system
signaling
molecules
[[5]Venegas
D.P.
De
La
Fuente
M.K.
Landskron
González
M.J.
Quera
Dijkstra
al.Short
chain
(SCFAs)mediated
epithelial
relevance
for
inflammatory
bowel
diseases.Front
Immunol.
2019;
10:
277https://doi.org/10.3389/fimmu.2019.00277Crossref
(584)
Therefore,
interaction
between
affect
response,
this
lead
either
path
regulatory
cells
pro-inflammation.
On
hand,
microbiota
drug
metabolism
provide
protection
against
pathogenic
organisms
through
colonization
competition
resources.
SCFAs,
propionate,
butyrate,
acetate,
lactate
microbiome.
They
interact
with
G
protein-coupled
receptors
induce
responses
via
signal
transduction
pathways.
mitogen-activated
kinases
(MAPK)
pathway
involved
pro-inflammatory
response
while
beta-arrestin-2
response.
SCFAs
bind
their
stimulate
IL-10
secretion
from
dendritic
macrophages
innate
immunity.
For
adaptive
promote
expansion
T
(Treg)
B
gut-lung
axis
Scholar],
all
which
overall
balance
modulation
Initial
findings
suggested
alterations
[6Hu
Y.
Feng
Wu
J.
Liu
F.
Zhang
Z.
Hao
al.The
signatures
discriminate
pulmonary
patients.Front
Cell
Infect
Microbiol.
9https://doi.org/10.3389/fcimb.2019.00090Crossref
(41)
Scholar,
7Li
Zhu
Liao
Q.
Wang
Wan
C.
Characterization
children
tuberculosis.BMC
Pediatr.
https://doi.org/10.1186/s12887-019-1782-2Crossref
(11)
8Namasivayam
Diarra
Diabate
Kone
al.Patients
infected
africanum
versus
distinct
microbiota.PLoS
Negl
Trop
Dis.
14e0008230Crossref
found
significant
decrease
diversity
fecal
samples
patients
compared
controls.
In
issue,
Naidoo
al.
different
compartments,
using
oral
wash,
induced
sputum,
stool
symptomatic
cases,
no-TB
controls,
household
contacts
previous
two
performed
peripheral
blood
transcriptome
comparative
analysis.
This
represents
first
study,
date,
comprehensive
thoughtful
selection
control
reduce
maximum
bias.
study
also
linked
changes
phenotype
during
TB.
authors
identified
profile
cases
close
contacts,
Erysipelotrichaceae,
Blautia,
Anaerostipes
stool,
precursor
inferred
pathways
short
known
[[9]Naidoo
C.C.
Nyawo
G.R.
Sulaiman
I.
B.G.
Turner
C.T.
Bu
K.
al.Anaerobe-enriched
predicts
tuberculosis.EBioMedicine.
67103374https://doi.org/10.1016/j.ebiom.2021.103374Summary
Full
Text
PDF
(2)
enriched
anaerobes
upregulation
related
microbiome-transcriptome
network
were
contacts.
Also,
anaerobes,
Paludibacter,
Lautropia
washes
sputum.
Overall
convincingly
shows
microbiome-inflammation
pattern
unique
group,
clearly
demonstrates
microbial-related
has
been
conditions,
cancer,
certainly
new
avenues
research
on
biomarkers
microbiome-targeted
prevention
adjuvant
treatments.
earlier
Namasivayam
order
Clostridiales
phylum
Firmicutes
members
Tenericutes
mouse
model
[[2]Namasivayam
similar
observations
made
Hu
[[10]Hu
Yang
Dong
Sun
L.
al.Gut
drugs.J
Infect.
78:
317-322Summary
(27)
These
commensals
highlights
some
mechanistic
differences
humans
mice,
outcome
similarities,
It
now
evident
community
metabolic
considerably
controls
Scholar,[10]Hu
differential
abundance
serve
biosignatures
active
individuals
potentially
used
therapeutic
target
immunomodulator
regimens
nutritional
severe
[[6]Hu
Probiotics,
prebiotics,
transfer
strategies
potential
options
interventions.
All
contributed
Conceptualization
(AMS,
DD,
JLH
MM),
data
curation
DD
formal
analysis
funding
aquisition
(AMS
investigation
methodology
Resources
(MM),
Supervision
validation
visualization
Writing
original
draft
writing
review
editing
MM).
There
no
conflicts
interest.
work
was
supported
National
Institutes
Health
(
R21AI148033
D43TW010543
).
Anaerobe-enriched
tuberculosisTB-specific
relationships
washes,
before
confounding
effects
antibiotics.
Specific
cases'
immunological
pathways,
supporting
microbiota's
Full-Text
Open
Access
Frontiers in Microbiology,
Год журнала:
2021,
Номер
12
Опубликована: Окт. 22, 2021
As
an
ancient
infectious
disease,
tuberculosis
(TB)
is
still
the
leading
cause
of
death
from
a
single
agent
worldwide.
Latent
TB
infection
(LTBI)
has
been
recognized
as
largest
source
new
cases
and
one
biggest
obstacles
to
achieving
aim
End
Strategy.
The
latest
data
indicate
that
considerable
percentage
population
with
LTBI
lack
differential
diagnosis
between
active
(aTB)
may
be
potential
reasons
for
high
morbidity
mortality
in
countries
burdens.
tuberculin
skin
test
(TST)
used
diagnose
>
100
years,
but
it
fails
distinguish
patients
those
aTB
people
who
have
received
Bacillus
Calmette–Guérin
vaccination.
To
overcome
limitations
TST,
several
tests
interferon-gamma
release
assays
developed,
such
Diaskintest,
C-Tb
test,
EC-Test,
T-cell
spot
assay,
QuantiFERON-TB
Gold
In-Tube,
Gold-Plus,
LIAISON
Plus
LIOFeron
TB/LTBI.
However,
these
methods
cannot
aTB.
investigate
why
all
aTB,
we
explained
concept
definition
expounded
on
immunological
mechanism
this
review.
In
addition,
outlined
research
status,
future
directions,
challenges
diagnosis,
including
novel
biomarkers
derived
Mycobacterium
hosts,
models
algorithms,
omics
technologies,
microbiota.
Frontiers in Microbiology,
Год журнала:
2023,
Номер
14
Опубликована: Март 27, 2023
Thousands
of
microorganisms
compose
the
human
gut
microbiota,
fighting
pathogens
in
infectious
diseases
and
inhibiting
or
inducing
inflammation
different
immunological
contexts.
The
microbiome
is
a
dynamic
complex
ecosystem
that
helps
proliferation,
growth,
differentiation
epithelial
immune
cells
to
maintain
intestinal
homeostasis.
Disorders
cause
alteration
this
microbiota
lead
an
imbalance
host's
regulation.
Growing
evidence
supports
microbial
community
associated
with
development
progression
inflammatory
diseases.
Therefore,
understanding
interaction
between
modulation
system
fundamental
mechanisms
involved
pathologies,
as
well
for
search
new
treatments.
Here
we
review
main
bacteria
capable
impacting
response
pathologies
discuss
by
which
can
alter
disease
outcomes.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(7), С. 4051 - 4051
Опубликована: Апрель 5, 2024
Bacterial
and
viral
respiratory
tract
infections
are
the
most
common
infectious
diseases,
leading
to
worldwide
morbidity
mortality.
In
past
10
years,
importance
of
lung
microbiota
emerged
in
context
pulmonary
although
mechanisms
by
which
it
impacts
intestinal
environment
have
not
yet
been
fully
identified.
On
contrary,
gut
microbial
dysbiosis
is
associated
with
disease
etiology
or/and
development
lung.
this
review,
we
present
an
overview
microbiome
modifications
occurring
during
infections,
namely,
reduced
community
diversity
increased
burden,
downstream
consequences
on
host–pathogen
interaction,
inflammatory
signals,
cytokines
production,
turn
affecting
progression
outcome.
Particularly,
focus
role
gut–lung
bidirectional
communication
shaping
inflammation
immunity
context,
resuming
both
animal
human
studies.
Moreover,
discuss
challenges
possibilities
related
novel
microbial-based
(probiotics
dietary
supplementation)
microbial-targeted
therapies
(antibacterial
monoclonal
antibodies
bacteriophages),
aimed
remodel
composition
resident
communities
restore
health.
Finally,
propose
outlook
some
relevant
questions
field
be
answered
future
research,
may
translational
relevance
for
prevention
control
infections.
Microbiology Spectrum,
Год журнала:
2022,
Номер
10(6)
Опубликована: Ноя. 9, 2022
Tuberculous
meningitis
(TBM),
the
most
lethal
and
disabling
form
of
tuberculosis
(TB),
may
be
related
to
gut
microbiota
composition,
warranting
further
study.
Here
we
systematically
compared
compositions
blood
cytokine
profiles
TBM
patients,
pulmonary
TB
healthy
controls.
Notably,
significant
dysbiosis
observed
in
patients
was
associated
with
markedly
high
proportions
Escherichia-Shigella
species
as
well
increased
levels
tumor
necrosis
factor
alpha
(TNF-α)
interleukin
6
(IL-6).
Next,
obtained
a
fecal
bacterial
isolate
from
patient
administered
it
via
oral
gavage
mice
order
develop
murine
model
for
use
exploring
mechanisms
underlying
relationship
between
microbial
TBM.
Thereafter,
cells
commensal
Escherichia
coli
(E.
coli)
were
isolated
by
then
inoculated
Mycobacterium
(M.
tuberculosis).
Subsequently,
these
exhibited
TNF-α
accompanied
downregulated
expression
tight
junction
protein
claudin-5,
brain
tissue
burden,
elevated
central
nervous
system
inflammation
relative
corresponding
indicators
controls
PBS
gavage.
Thus,
our
results
demonstrated
that
signature
dysbiotic
microbiome
profile
containing
proportion
E.
potentially
an
circulating
level
patients.
Collectively,
suggest
modulation
holds
promise
new
strategy
preventing
or
alleviating
IMPORTANCE
As
severe
tuberculosis,
pathogenesis
tuberculous
(TBM)
is
still
unclear.
Gut
plays
important
role
variety
diseases.
However,
has
not
been
identified.
In
study,
composition
plasma
noted
A
shown
increase
downregulate
claudin-5
model.
Gavage
administration
aggravated
burden
inflammatory
responses
after
M.
infection.
Dysbiosis
promising
therapeutic
target
biomarker
prevention
treatment.
Biomedicine & Pharmacotherapy,
Год журнала:
2021,
Номер
143, С. 112108 - 112108
Опубликована: Сен. 21, 2021
Trillions
of
beneficial
and
hostile
microorganisms
live
in
the
human
respiratory
gastrointestinal
tracts,
which
act
as
gatekeepers
maintaining
health,
i.e.,
protecting
body
from
pathogens
by
colonizing
mucosal
surfaces
with
microbiota-derived
antimicrobial
metabolites
such
short-chain
fatty
acids
or
host-derived
cytokines
chemokines.
It
is
widely
accepted
that
microbiome
interacts
each
other
host
a
mutually
relationship.
Microbiota
tract
may
also
play
crucial
role
immune
homeostasis,
maturation,
maintenance
physiology.
Anti-TB
antibiotics
cause
dysbiosis
lung
intestinal
microbiota,
affecting
colonization
resistance
making
more
susceptible
to
Mycobacterium
tuberculosis
(M.
tuberculosis)
infection.
This
review
discusses
recent
advances
our
understanding
microbiota
composition,
lungs
related
health
diseases,
sequencing
analysis,
bloodstream,
lymphatic
system
underpin
gut-lung
axis
M.
tuberculosis-infected
humans
animals.
We
discuss
interactions
system,
TB
pathogenesis,
impact
anti-TB
antibiotic
therapy
on
animals,
humans,
drug-resistant
individuals.
Global Change Biology,
Год журнала:
2023,
Номер
29(20), С. 5816 - 5828
Опубликована: Июль 24, 2023
Abstract
Climate
change
and
climate‐driven
increases
in
infectious
disease
threaten
wildlife
populations
globally.
Gut
microbial
responses
are
predicted
to
either
buffer
or
exacerbate
the
negative
impacts
of
these
twin
pressures
on
host
populations.
However,
examples
that
document
how
gut
communities
respond
long‐term
shifts
climate
associated
risk,
consequences
for
survival,
rare.
Over
past
two
decades,
wild
meerkats
inhabiting
Kalahari
have
experienced
rapidly
rising
temperatures,
which
is
linked
spread
tuberculosis
(TB).
We
show
over
same
period,
faecal
microbiota
this
population
has
become
enriched
Bacteroidia
impoverished
lactic
acid
bacteria
(LAB),
a
group
including
Lactococcus
Lactobacillus
considered
mutualists.
These
occurred
within
individuals
yet
were
compounded
generations,
better
explained
by
mean
maximum
temperatures
than
rainfall
previous
year.
Enriched
additionally
with
TB
exposure
disease,
dry
season
poorer
body
condition,
factors
all
directly
reduced
future
survival.
Lastly,
abundances
LAB
taxa
independently
positively
while
did
not
predict
Together,
results
point
towards
extreme
driving
an
expansion
disease‐associated
pathobiome
loss
beneficial
taxa.
Our
study
provides
first
evidence
from
longitudinally
sampled
restructuring
microbiota,
changes
may
amplify
through
While
plastic
response
host‐associated
microbiotas
key
adaptation
under
normal
environmental
fluctuations,
temperature
might
lead
breakdown
coevolved
host–mutualist
relationships.
BioNanoScience,
Год журнала:
2023,
Номер
13(1), С. 249 - 277
Опубликована: Янв. 11, 2023
Toxoplasma
gondii
and
Mycobacterium
tuberculosis
are
pathogens
that
harmful
to
humans.
When
these
diseases
interact
in
humans,
the
result
is
typically
fatal
public
health.
Several
investigations
on
relationship
between
M.
T.
infections
have
found
there
a
strong
correlation
them
with
each
infection
having
reciprocal
effect
other.
TB
may
contribute
reactivation
of
innate
toxoplasmosis
or
enhance
susceptibility
new
infection,
toxoplasma
co-infection
worsen
severity
pulmonary
tuberculosis.
As
consequence,
an
earnest
urgent
necessity
generate
novel
therapeutics
can
subdue
challenges.
Selenium
nanostructures'
compelling
properties
been
shown
be
successful
treatment
for
gondii.
Despite
fact
selenium
(Se)
offers
many
health
advantages
people,
it
also
has
narrow
therapeutic
window;
therefore,
consuming
too
much
either
inorganic
organic
compounds
based
hazardous.
Compared
both
Se,
Se
nanoparticles
(SeNPs)
less
They
biocompatible
excellent
selectively
targeting
specific
cells.
this
review
conducted
summary
efficacy
biogenic
NPs
(TB)
toxoplasmosis.
tuberculosis,
gondii,
their
were
all
briefly
described.
International Journal of Environmental Research and Public Health,
Год журнала:
2021,
Номер
18(22), С. 12220 - 12220
Опубликована: Ноя. 21, 2021
Tuberculosis
is
one
of
the
most
common
infectious
diseases
and
causes
death
worldwide.
Over
last
decades,
significant
research
effort
has
been
directed
towards
defining
understanding
pathogenesis
tuberculosis
to
improve
diagnosis
therapeutic
options.
Emerging
scientific
evidence
indicates
a
possible
role
human
microbiota
in
pathophysiology
tuberculosis,
response
therapy,
clinical
outcomes,
post-treatment
outcomes.
Although
studies
on
are
limited,
published
data
recent
years,
both
from
experimental
studies,
suggest
that
better
gut–lung
microbiome
axis
microbiome–immune
crosstalk
could
shed
light
specific
pathogenetic
mechanisms
Mycobacterium
infection
identify
new
targets.
In
this
review,
we
address
current
knowledge
host
immune
responses
against
infection,
emerging
how
gut
lung
can
modulate
susceptibility
available
use
probiotic–antibiotic
combination
therapy
for
treatment
gaps
future
priorities
field.
PubMed,
Год журнала:
2025,
Номер
19(1), С. 21 - 28
Опубликована: Янв. 1, 2025
Other
microbial
infections
in
pulmonary
tuberculosis
(TB)
patients
pose
significant
challenges,
complicating
treatment
outcomes
and
potentially
increasing
mortality
rates.
This
study
aims
to
characterize
the
bacterial
fungal
profiles
TB
patients.